TopAlliance Biosciences

Focus: TopAlliance Biosciences is a monoclonal antibody-focused biotech company headquartered in Menlo Park, CA, currently in early-stage clinical development with multiple Phase 1 programs.

Unknown

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About TopAlliance Biosciences

AI assessmentNot Hiring

No open roles listed right now. Follow TopAlliance Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

ATRA

Triple-negative Breast Cancer

N/A

Clinical Trials (1)

NCT06371274A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

N/A

Help build intelligence for TopAlliance Biosciences

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused monoclonal antibody platform with potential oncology applications across multiple solid tumors
Early-stage opportunity to influence development of 4 distinct programs from Phase 1 onwards
Menlo Park location provides access to Silicon Valley biotech ecosystem and talent networks

Watch Out For

Extremely limited headcount and hiring (only 1 active role currently) suggests minimal growth trajectory or resource constraints
All programs remain in Phase 1 with no Phase 2+ catalysts, indicating early-stage execution risk and extended path to clinical validation
Lack of public financial data, revenue, funding information, and publications raises transparency concerns about company stability and capability

Generated by Claude from TopAlliance Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Part A

Advanced Malignancies

Phase 1

Clinical Trials (1)

NCT03474640Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Phase 1

TAB006

Previously Treated, Advanced

Phase 1

Clinical Trials (1)

NCT05253105A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

Phase 1

TAB004

Advanced Unresectable Solid Tumor

Phase 1

Clinical Trials (1)

NCT04137900Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 4 clinical trials

Top TAs: Oncology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Oncology

2 pipeline

Marketed

Pipeline